TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies.

MLA

Dianat-Moghadam, Hassan, et al. “TRAIL in Oncology: From Recombinant TRAIL to Nano- and Self-Targeted TRAIL-Based Therapies.” Pharmacological Research, vol. 155, May 2020, p. 104716. EBSCOhost, https://doi.org/10.1016/j.phrs.2020.104716.

APA

Dianat-Moghadam, H., Heidarifard, M., Mahari, A., Shahgolzari, M., Keshavarz, M., Nouri, M., & Amoozgar, Z. (2020). TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies. Pharmacological Research, 155, 104716. https://doi.org/10.1016/j.phrs.2020.104716

Chicago

Dianat-Moghadam, Hassan, Maryam Heidarifard, Amir Mahari, Mehdi Shahgolzari, Mohsen Keshavarz, Mohammad Nouri, and Zohreh Amoozgar. 2020. “TRAIL in Oncology: From Recombinant TRAIL to Nano- and Self-Targeted TRAIL-Based Therapies.” Pharmacological Research 155 (May): 104716. doi:10.1016/j.phrs.2020.104716.